COMPARISON OF EFFICACY OF PHENYTOIN AND LEVETIRACETAM FOR PREVENTION OF EARLY POST TRAUMATIC SEIZURES
AbstractBackground: The incidence of early post-traumatic seizures after civilian traumatic brain injury ranges 4–25%. The control of early post-traumatic seizure is mandatory because these acute insults may add secondary damage to the already damaged brain with poor outcome. Prophylactic use of anti-epileptic drugs have been found to be have variable efficacy against early post-traumatic seizures. The objective of this study was to compare the efficacy of Phenytion and Levetiracetam in prevention of early post-traumatic seizures in moderate to severe traumatic brain injury. Methods: This Randomized Controlled Trial was conducted in department of Neurosurgery, Ayub Medical College, Abbottabad from March, 2012 to March 2014. The patients with moderate to severe head injury were randomly allocated in two groups. Patients in group A were given phenytoin and patients in group B were given Levetiracetam. Patients were followed for one week to detect efficacy of drug in terms of early post traumatic seizures. Results: The 154 patients included in the study were equally divided into two groups. Out of 154 patients 115 (74.7%) were male while 29 (25.3%) were females. Age of patients ranges from 7–48 (24.15±9.56) years. Ninety one (59.1%) patients had moderate head injury while 63 (40.9%) patients had severe head injury. Phenytoin was effective in preventing early post traumatic seizures in 73 (94.8%) patients whereas Levetiracetam effectively controlled seizures in 70 (90.95%) cases (p-value of .348). Conclusion: There is no statistically significant difference in the efficacy of Phenytoin and Levetiracetam in prophylaxis of early post-traumatic seizures in cases of moderate to severe traumatic brain injury.Keywords: Phenytoin; Levetiracetam; Seizures; Post-traumatic; Epilepsy; Trauma; Head injury
Shukla D, Devi BI. Mild traumatic brain injuries in adults. J Neurosci Rural Pract 2010;1(2):82–8
Moppett IK. Traumatic brain injury: assessment, resuscitation and early management. Br J Anaesth 2007;99(1):18–31.
Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I. Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol 2011;2011:765923.
Khan AA, Banerjee A. The role of prophylactic anticonvulsants in moderate to severe head injury. Int J Emerg Med 2010 22;3(3):187–91.
Misra UK, Kalita J. Management of provoked seizure. Ann Indian Acad Neurol 2011;14(1):2–8.
Bozić K. [Prophylactic use of antiepileptic drugs for posttraumatic epilepsy].Med Pregl. 2009;62(11-12):501–3.
Odebode OT, Sanya EO. Outcome of early posttraumatic seizure: an experience in Nigeria. Niger J Clin Pract 2008;11(3):193–8.
Liesemer K, Bratton SL, Zebrack CM, Brockmeyer D, Statler KD. Early post-traumatic seizures in moderate to severe pediatric traumatic brain injury: rates, risk factors, and clinical features. J Neurotrauma 2011;28(5):755–62.
Liu KC, Bhardwaj A. Use of prophylactic anticonvulsants in neurologic critical care: a critical appraisal. Neurocrit Care 2007;7(2):175–84.
Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010;12(2):165–72.
Taylor S, Heinrichs RJ, Janzen JM, Ehtisham A. Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage. Neurocrit Care 2011;15(1):80–4.
Brouwers MC, Chambers A, Perry J. Can surveying practitioners about their practices help identify priority clinical practice guideline topics? BMC Health Serv Res 2003;3(1):23.
Zafar SN, Khan AA, Ghauri AA, Shamim MS. Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis. BMC Neurol 2012;12:30.
Tolias CM, Bullock MR. Critical appraisal of neuroprotection trials in head injury: what have we learned? NeuroRx 2004;1(1):71–9.
Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003;60(1):10–6.
Chan KH, Tharakan J, Pal HK, Khan N, Tan YC. Risk Factors and Phenytoin Prophylaxis for Early Post-Traumatic Seizures among Patients with Traumatic Brain Injury. Malays J Med Sci 2010;17(4):36–43.
Helmy A, Vizcaychipi M, Gupta AK. Traumatic brain injury: intensive care management. Br J Anaesth 2007;99(1):32–42.
Sahin S, Comert A, Akin O, Ayalp S, Karsidag S. Cutaneous drug eruptions by current antiepileptics: case reports and alternative treatment options. Clin Neuropharmacol 2008;31(2):93–6.
Cohan P, Wang C, McArthur DL, Cook SW, Dusick JR, Armin B, et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med 2005;33(10):2358–66.
Michelucci R. Optimizing therapy of seizures in neurosurgery. Neurology 2006;67(12 Suppl 4):S14–8.
Spencer DD, Jacobi J, Juenke JM, Fleck JD, Kays MB. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients. Pharmacotherapy 2011;31(10):934–41.
Al-Kuwaiti A, Hefny AF, Bellou A, Eid HO, Abu-Zidan FM. Epidemiology of head injury in the United Arab Emirates. Ulus Travma Acil Cerrahi Derg 2012;18(3):213–8.
Yavuz MS, Asirdizer M, Cetin G, Günay Balci Y, Altinkok M. The correlation between skull fractures and intracranial lesions due to traffic accidents. Am J Forensic Med Pathol 2003;24(4):339–45.
Gupta PK, Krishna A, Dwivedi AN, Gupta K, Madhu B, Gouri G, et al. CT scan findings and outcomes of head injury patients: A cross sectional study. J Pioneer Med Sci. 2011;1(3):78–82.
Igun GO. Predictive indices in traumatic intracranial haematomas. East Afr Med J 2000;77(1):9–12.
Haltiner AM, Newell DW, Temkin NR, Dikmen SS, Winn HR. Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis. J Neurosurg 1999;91(4):588–92.
Milligan TA, Hurwitz S, Bromfield EB. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 2008;71(9):665–9.
Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N, Jankowitz BT, et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus 2008;25(4):E3.
Szaflarski JP, Meckler JM, Szaflarski M, Shutter LA, Privitera MD, Yates SL. Levetiracetam use in critically ill patients. Neurocrit Care 2007;7(2):140–7.
Fountain NB. Should levetiracetam replace phenytoin for seizure prophylaxis after neurosurgery? Epilepsy Curr 2009;9(3):71–2.
Cotton BA, Kao LS, Kozar R, Holcomb JB. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis. J Trauma 2011;71(2):375–9.
Kazerooni R, Bounthavong M. Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury. Clinicoecon Outcomes Res 2010;2:15–23.
Inaba K, Menaker J, Branco BC, Gooch J, Okoye OT, Herrold J, et al. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. J Trauma Acute Care Surg 2013;74(3):766–71